PHARMACOKINETICS OF INTRAVENOUS AND INTRAPERITONEAL CEFUROXIME IN PATIENTS UNDERGOING PERITONEAL-DIALYSIS

被引：0
|
作者：
LOCAL, FK
MUNRO, AJ
KERR, DNS
SUSSMAN, M
机构：
[1] GLAXO GRP RES,DEPT HUMAN PHARMACOL,GREENFORD,MIDDLESEX,ENGLAND
[2] UNIV NEWCASTLE UPON TYNE,DEPT MED,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
[3] UNIV NEWCASTLE UPON TYNE,DEPT MICROBIOL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
来源：
CLINICAL NEPHROLOGY | 1981年 / 16卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：40 / 43
页数：4
相关论文
共 50 条
  • [31] PHARMACOKINETICS OF VANCOMYCIN IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    BLEVINS, RD
    HALSTENSON, CE
    SALEM, NG
    MATZKE, GR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) : 603 - 606
  • [32] PHARMACOKINETICS OF CEFTIZOXIME IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    BURGESS, ED
    BLAIR, AD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (02) : 237 - 239
  • [33] PHARMACOKINETICS OF INTRAPERITONEAL MOXALACTAM IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    MORSE, GD
    JANICKE, DM
    CAFARELL, RF
    WALSHE, JJ
    VENUTO, RC
    APICELLA, MA
    JUSKO, WJ
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 493 - 493
  • [34] PHARMACOKINETICS AND PERITONEAL CLEARANCE OF CEFTIZOXIME IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    GROSS, ML
    FREIMER, EH
    SOMANI, P
    CLINICAL RESEARCH, 1982, 30 (04): : A753 - A753
  • [35] COMPARATIVE-STUDY OF THE PHARMACOKINETICS OF VARIOUS BETA-LACTAMS AFTER INTRAVENOUS AND INTRAPERITONEAL ADMINISTRATION IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    IMADA, A
    ITAGAKI, N
    HASEGAWA, H
    HORIUCHI, A
    DRUGS, 1988, 35 : 82 - 87
  • [36] PERITONEAL PHARMACOKINETICS OF LIDOCAINE IN PERITONEAL-DIALYSIS PATIENTS
    DIPAOLO, N
    ROSSI, P
    GAGGIOTTI, E
    DEMIA, M
    CAPOTONDO, L
    SANSONI, E
    SANGIACOMO, FM
    PERITONEAL DIALYSIS BULLETIN, 1985, 5 (04): : 268 - 268
  • [37] COMPARATIVE-STUDY OF INTRAPERITONEAL AND INTRAVENOUS VANCOMYCIN PHARMACOKINETICS DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    MORSE, GD
    FAROLINO, DF
    APICELLA, MA
    WALSHE, JJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) : 173 - 177
  • [38] PHARMACOKINETICS OF INTRAPERITONEAL CEFOTAXIME TREATMENT OF PERITONITIS IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    PETERSEN, J
    STEWART, RDM
    CATTO, GRD
    EDWARD, N
    NEPHRON, 1985, 40 (01): : 79 - 82
  • [39] COMPARISON OF INTRAVENOUS (IV) AND INTRAPERITONEAL (IP) ADMINISTRATION OF CEFTIZOXIME IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD)
    GROSS, ML
    NALLY, JV
    HIGGINS, JT
    FREIMER, EH
    SOMANI, P
    KIDNEY INTERNATIONAL, 1983, 23 (01) : 148 - 148
  • [40] PHARMACOKINETICS OF CEFOTAXIME IN PATIENTS UNDERGOING HEMODIALYSIS AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    HASEGAWA, H
    IMADA, A
    HORIUCHI, A
    NISHII, Y
    FUKUSHIMA, M
    KUROKAWA, E
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 : 135 - 142
12345